Neurological models · CBG
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · PMID 25252936
Two experimental mouse models
- Studied preparation
- CBG administered in controlled experimental regimens.
- Population / model
- R6/2 mice and mice exposed to a chemical model of Huntington-like injury.
- What was observed
- Behavioral and molecular effects differed between the two models.
Preclinical models cannot establish clinical benefit in people with Huntington’s disease or validate a retail formulation.
Journal issue · Source checked 2026-10-25
Sources, registration and terms
Citation and publication date recorded; peer-review/preprint status not separately classified.
PMC full-text link is recorded; current access and reuse rights are not verified here.
No registration recorded for this paper; this is not a claim that none exists.